Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIC Allo-HSCT in Multiple Myeloma
NCT00802568Phase 2Completed
- Sponsor
- Institut Paoli-Calmettes
- Start
- Apr 2007
- Primary completion
- May 2011
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, busulfan, antithymocyte globulin rabbit in multiple myeloma (MM), sponsored by Institut Paoli-Calmettes. Started Apr 2007; status: completed.
02
Drugs
fludarabinebusulfanantithymocyte globulin rabbit
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00802568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00802568.